TuHURA Biosciences's market cap is currently $139.54M. The company's EPS TTM is $-75.233; its P/E ratio is ―; TuHURA Biosciences is scheduled to report earnings on February 18, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Jun 21	Jun 20
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ 0.00	$ 0.00	$ 0.00	$ -32.00K	$ -10.00K
Operating Income	$ -29.76M	$ -9.93M	$ -7.25M	$ -21.57M	$ -8.14M
EBITDA	$ -29.12M	$ -9.56M	$ -6.01M	$ -38.15M	$ -9.12M
Net Income	$ -29.32M	$ -9.37M	$ -7.02M	$ -38.30M	$ -9.13M
Balance Sheet
Cash & Short-Term Investments	$ 3.67M	$ 14.25M	$ 5.55M	$ 10.54M	$ 2.39M
Total Assets	$ 4.36M	$ 15.20M	$ 6.40M	$ 13.54M	$ 2.94M
Total Debt	$ 2.34M	$ 138.22K	$ 644.07K	$ 0.00	$ 0.00
Net Debt	$ -1.32M	$ -14.11M	$ -4.90M	$ -10.54M	$ -2.39M
Total Liabilities	$ 5.92M	$ 2.89M	$ 7.15M	$ 2.96M	$ 2.67M
Stockholders' Equity	$ -1.56M	$ 12.30M	$ -747.82K	$ 10.58M	$ 263.00K
Cash Flow
Free Cash Flow	$ -12.03M	$ -7.54M	$ -6.57M	$ -18.87M	$ -7.93M
Operating Cash Flow	$ -11.95M	$ -7.51M	$ -6.56M	$ -18.86M	$ -7.93M
Investing Cash Flow	$ -1.30M	$ -36.28K	$ -3.28K	$ 964.00K	$ 0.00
Financing Cash Flow	$ 2.66M	$ 16.25M	$ 7.04M	$ 26.04M	$ 6.60M

Currency in USD

TuHURA Biosciences Earnings and Revenue History

Income Statement >

TuHURA Biosciences Debt to Assets

Balance Sheet >

TuHURA Biosciences Cash Flow

Cash Flow >

TuHURA Biosciences Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing